BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioTech Medics, Inc. (BTMD) Issues Clarification Regarding Prior Press Release


6/21/2010 9:36:06 AM

LAS VEGAS, NV--(Marketwire - June 20, 2010) - BioTech Medics, Inc. (PINKSHEETS: BMCS) On June 9, 2010 BioTech announced in compliance of SEC "material event" regulations that a Federal Grand Jury had criminally indicted 10 persons (none of whom are current board members) regarding alleged illegal stock manipulation, theft, forgery of shares and crimes.

The Company quoted from the indictment in "Count Ten" and "Count Eleven" that the government is seeking individual disgorgement monetary sums regarding, "to wit: stock of BioTech Medics, Inc."

The Company quoted the indictment "Forfeiture Allegation Ten" and "Forfeiture Allegation Eleven" sums sought and aggregated the sums regarding the "in personam criminal forfeiture." The Company also properly stated regarding those indicted that: "All are considered innocent until adjudged guilty."

Due to the fact the indictment is ambiguous and not clear as to how those sums were allocated the Company aggregated the two separate and distinct forfeiture quoted sums specifying "BioTech." Due to the fact the indictment is also seeking RICO (Racketeering) forfeiture, the forfeiture sums may be subject to treble damages (but again this is not clear).

So to avoid any confusion and/or misunderstanding of the prior press release the Company would like to restate and clarify the previous press release and opinion expressed.

Any quote from the indictment of any sums relating to the aggregate of the alleged forfeiture sums should not be confused and/or misunderstood and/or considered to reflect in any way whatsoever regarding any past, present and/or future value and/or benefit to BioTech and/or its shareholders by the grand jury. Only a judge and jury subsequent to deliberating at trial on all of the evidence presented will a determination be made. That also will not be the final resolve.

According to statements published at an April 2010 Asset Forfeiture Conference held in Florida at which Richard Weber, Chief of the Asset Forfeiture & Money Laundering Section of the U.S. Department of Justice was a speaker, a brochure to the event put in perspective challenges facing these types of enforcement actions: "Every day in the United States, criminals earn $1.4 billion from their crimes. Of the $500 billion they earn..." (steal) "...annually, they lose only $4 billion to law enforcement forfeitures. If you're a criminal you run less than a 1% chance that your criminal wealth will be confiscated."

Since the indictments BMCS is still experiencing shorting and illegal manipulation.


Contact:
Tom Wood
972-274-5533



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES